A randomised phase III trial of adjuvant radio-chemotherapy comparing Irinotecan, 5FU and Leucovorin to 5FU and Leucovorin in patients with rectal cancer: a Hellenic Cooperative Oncology Group Study
Φόρτωση...
Ημερομηνία
Συγγραφείς
Kalofonos, H. P.
Bamias, A.
Koutras, A.
Papakostas, P.
Basdanis, G.
Samantas, E.
Karina, M.
Misailidou, D.
Pisanidis, N.
Pentheroudakis, G.
Τίτλος Εφημερίδας
Περιοδικό ISSN
Τίτλος τόμου
Εκδότης
Περίληψη
Τύπος
Είδος δημοσίευσης σε συνέδριο
Είδος περιοδικού
peer-reviewed
Είδος εκπαιδευτικού υλικού
Όνομα συνεδρίου
Όνομα περιοδικού
Eur J Cancer
Όνομα βιβλίου
Σειρά βιβλίου
Έκδοση βιβλίου
Συμπληρωματικός/δευτερεύων τίτλος
Περιγραφή
The primary objective was to compare the 3-year survival of rectal cancer patients randomised postoperatively to irinotecan (IRI), Leucovorin (LV) and bolus 5-fluorouracil (5FU) or LV-bolus 5FU with radiotherapy. Secondary objectives included disease-free survival, local relapse and toxicity. The study included 321 eligible patients. The treatment consisted of weekly administration of IRI 80 mg/m(2) intravenously (IV), LV 200 mg/m(2) and 5FU 450 mg/m(2) bolus (arm A) versus LV 200 mg/m(2) and 5FU 450 mg/m(2) IV bolus (arm B). One cycle included four infusions and treatment was continued for a total of six cycles. The first cycle was followed by pelvic irradiation plus 5FU. There were no differences between the arms in 3-year overall, disease-free and local relapse-free survival. Grades 3 and 4 toxicity was similar in both the arms with the exception of leucopaenia, neutropaenia and alopecia, which were higher in the IRI arm. IRI added to adjuvant radiochemotherapy with LV and bolus 5FU was not shown to improve survival, whereas the incidence of severe leucopaenia was significantly higher in the IRI arm.
Περιγραφή
Λέξεις-κλειδιά
Adenocarcinoma/*drug therapy/*radiotherapy, Adult, Aged, Antineoplastic Combined Chemotherapy Protocols/*administration & dosage, Camptothecin/administration & dosage/analogs & derivatives, Chemotherapy, Adjuvant, Cohort Studies, Drug Administration Schedule, Female, Fluorouracil/administration & dosage, Humans, Leucovorin/administration & dosage, Male, Middle Aged, Radiotherapy, Adjuvant, Rectal Neoplasms/*drug therapy/*radiotherapy, Survival Analysis, Treatment Outcome
Θεματική κατηγορία
Παραπομπή
Σύνδεσμος
http://www.ncbi.nlm.nih.gov/pubmed/18639450
http://ac.els-cdn.com/S0959804908004115/1-s2.0-S0959804908004115-main.pdf?_tid=890b8a96e450a077c87ceec8dd1e30b1&acdnat=1333954231_c1c072b4352eb2501f681a6e47fbd12b
http://ac.els-cdn.com/S0959804908004115/1-s2.0-S0959804908004115-main.pdf?_tid=890b8a96e450a077c87ceec8dd1e30b1&acdnat=1333954231_c1c072b4352eb2501f681a6e47fbd12b
Γλώσσα
en
Εκδίδον τμήμα/τομέας
Όνομα επιβλέποντος
Εξεταστική επιτροπή
Γενική Περιγραφή / Σχόλια
Ίδρυμα και Σχολή/Τμήμα του υποβάλλοντος
Πανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικής